Literature DB >> 326173

Pediatric clinical pharmacology and the "therapeutic orphan".

A K Done, S N Cohen, L Strebel.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 326173     DOI： 10.1146/annurev.pa.17.040177.003021

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  7 in total

Review 1.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 2.  Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D M Campoli-Richards; T E Lackner; J P Monk
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

Review 3.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.

Authors:  Michael Rieder
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Jan-Feb

5.  Pharmacokinetics of intramuscular ceforanide in infants, children, and adolescents.

Authors:  A S Dajani; M C Thirumoorthi; R E Bawdon; J A Buckley; M Pfeffer; D R Van Harken; R D Smyth
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

6.  Pharmacokinetics of vincristine sulfate in children.

Authors:  V S Sethi; J C Kimball
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 7.  Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Authors:  Eva Germovsek; Charlotte I S Barker; Mike Sharland; Joseph F Standing
Journal:  Clin Pharmacokinet       Date:  2019-01       Impact factor: 5.577
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.